This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1966;11(5):285-92.

doi: 10.1159/000220462.

Rifampicin: a new orally active rifamycin

N Maggi, C R Pasqualucci, R Ballotta, P Sensi

PMID: 5958716
DOI: 10.1159/000220462

Rifampicin: a new orally active rifamycin

N Maggi et al. Chemotherapy. 1966.

. 1966;11(5):285-92.

doi: 10.1159/000220462.

Authors

N Maggi, C R Pasqualucci, R Ballotta, P Sensi

PMID: 5958716
DOI: 10.1159/000220462

No abstract available

PubMed Disclaimer

Similar articles

Multiple emulsions containing rifampicin.
Khopade AJ, Jain NK. Khopade AJ, et al. Pharmazie. 1999 Dec;54(12):915-9. Pharmazie. 1999. PMID: 10631755 Clinical Trial.
[Early results of rifampicin treatment combined with other antitubercular agents in patients with recent and chronic pulmonary tuberculosis].
Zduńczyk-Pawełek H, Kochnowski G, Polońska A. Zduńczyk-Pawełek H, et al. Pneumonol Pol. 1979 Feb;47(2):97-105. Pneumonol Pol. 1979. PMID: 432119 Polish. No abstract available.
Preparation, properties and metabolism of 5,6-monoepoxyretinoic acid.
John KV, Lakshmanan MR, Cama HR. John KV, et al. Biochem J. 1967 May;103(2):539-43. doi: 10.1042/bj1030539. Biochem J. 1967. PMID: 6032985 Free PMC article.
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
van Ingen J, Aarnoutse RE, Donald PR, Diacon AH, Dawson R, Plemper van Balen G, Gillespie SH, Boeree MJ. van Ingen J, et al. Clin Infect Dis. 2011 May;52(9):e194-9. doi: 10.1093/cid/cir184. Clin Infect Dis. 2011. PMID: 21467012 Review.
The near future: improving the activity of rifamycins and pyrazinamide.
Mitchison DA, Fourie PB. Mitchison DA, et al. Tuberculosis (Edinb). 2010 May;90(3):177-81. doi: 10.1016/j.tube.2010.03.005. Epub 2010 Apr 9. Tuberculosis (Edinb). 2010. PMID: 20382083 Review.

See all similar articles

Cited by

Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis.
Hasan S, Daugelat S, Rao PS, Schreiber M. Hasan S, et al. PLoS Comput Biol. 2006 Jun 9;2(6):e61. doi: 10.1371/journal.pcbi.0020061. Epub 2006 Jun 9. PLoS Comput Biol. 2006. PMID: 16789813 Free PMC article.
Spatial structure facilitates the accumulation and persistence of antibiotic-resistant mutants in biofilms.
France MT, Cornea A, Kehlet-Delgado H, Forney LJ. France MT, et al. Evol Appl. 2018 Dec 22;12(3):498-507. doi: 10.1111/eva.12728. eCollection 2019 Mar. Evol Appl. 2018. PMID: 30828370 Free PMC article.
Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic.
Andersen SJ, Quan S, Gowan B, Dabbs ER. Andersen SJ, et al. Antimicrob Agents Chemother. 1997 Jan;41(1):218-21. doi: 10.1128/AAC.41.1.218. Antimicrob Agents Chemother. 1997. PMID: 8980786 Free PMC article.
Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury.
Hou W, Nsengimana B, Yan C, Nashan B, Han S. Hou W, et al. Front Pharmacol. 2022 Oct 20;13:1022809. doi: 10.3389/fphar.2022.1022809. eCollection 2022. Front Pharmacol. 2022. PMID: 36339603 Free PMC article. Review.
Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
Chen W, Lin W, Yu N, Zhang L, Wu Z, Chen Y, Li Z, Gong F, Li N, Chen X, He X, Wu Y, Zeng X, Yueh Y, Xu R, Ji G. Chen W, et al. Int J Nanomedicine. 2022 Nov 18;17:5431-5446. doi: 10.2147/IJN.S379917. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36426375 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Other Literature Sources
- The Lens - Patent Citations Database